Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Warning Draws Solid Line Between Steroid Products And Supplements

This article was originally published in The Tan Sheet

Executive Summary

FDA's enforcement approach toward a firm warned about marketing synthetic steroids as dietary supplements represents a more watertight legal strategy than the agency has used in similar scenarios
Advertisement

Related Content

Synthetics Stance In NDI Guidance Raises Red Flag For Industry
Synthetics Stance In NDI Guidance Raises Red Flag For Industry
Guilty Plea In VMG Steroid Case Weighs On Firm, Not DSHEA Critics
Steroids Sold As Supplements Targeted In FDA Actions, Congressional Hearing
CRN Stands Up Against U.S. Sports Official's Criticism Of Supplement Quality
“Disturbing” DHEA Ads, Hill Interest Prompt CRN’s Marketing Guidelines
Are Designer Steroids Dietary Ingredients? FDA Warning Letter Skirts Issue
FDA Miscasts “Dietary Substance” In Statements On DSHEA – Petition
Andro Targeted By FDA In Coordination With Capitol Hill Action
Andro Targeted By FDA In Coordination With Capitol Hill Action

Topics

Advertisement
UsernamePublicRestriction

Register

PS103182

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel